Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Interview with the Innovators
2022
Market Access
Market Access
Interview with the Innovators
Patients Are at the Heart of Everything We Do
Jenny Fox
,
Wendy Interiano
,
Mark Peters II, PharmD
,
Shannon Stempkowski
Read More
Market Access
Interview with the Innovators
A Passion for Scientific Innovation and a Company Culture That Values Customers Drive the Teams at Genmab to Discover Cutting-Edge Solutions for People with Cancer
Brad Bailey
,
Chris Cozic
Read More
Market Access
Interview with the Innovators
Genmab Unleashes the Power of Strategic Alliances to Advance the Science of Therapeutic Antibodies for People with Cancer
Robyn Bilmes
,
Leslie Amendola
Read More
Market Access
Interview with the Innovators
Genmab Is Developing a World-Class Antibody Portfolio with the Hope to Bring the Right Cancer Therapy for the Right Patient
Kate Sasser
,
Hisham Hamadeh
Read More
Market Access
Interview with the Innovators
Genmab Is Ready to Enter the US Market to Help Improve the Lives of People with Cancer
Ron Graybill
,
Brad Bailey
Read More
Market Access
Interview with the Innovators
Introducing Genmab-Rooted in Science and Inspired by Patients to Transform the Future of Cancer Treatment
Anthony Mancini
,
Ron Graybill
Read More
Interview with the Innovators
Unclear Diagnoses in Patients with Metastatic Disease
Ralph V. Boccia, MD, FACP
Read More
Interview with the Innovators
The bioT3 platform
Ralph V. Boccia, MD, FACP
Read More
Interview with the Innovators
Clinical Validation of CancerTYPE ID
Ralph V. Boccia, MD, FACP
Read More
Interview with the Innovators
CancerTYPE ID in the Clinic
Ralph V. Boccia, MD, FACP
Read More
1
2
Page 1 of 2
Results 1 - 10 of 17